Benitec Biopharma (BNTC) Free Cash Flow (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Free Cash Flow for 7 consecutive years, with -$8.2 million as the latest value for Q2 2025.

  • Quarterly Free Cash Flow fell 148.65% to -$8.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$23.6 million through Jun 2025, down 21.6% year-over-year, with the annual reading at -$23.6 million for FY2025, 20.55% down from the prior year.
  • Free Cash Flow hit -$8.2 million in Q2 2025 for Benitec Biopharma, down from -$3.1 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$2.0 million in Q1 2021 to a low of -$8.2 million in Q2 2025.
  • Historically, Free Cash Flow has averaged -$4.7 million across 5 years, with a median of -$4.4 million in 2021.
  • Biggest five-year swings in Free Cash Flow: crashed 160.6% in 2021 and later skyrocketed 50.13% in 2025.
  • Year by year, Free Cash Flow stood at -$3.3 million in 2021, then tumbled by 76.25% to -$5.9 million in 2022, then increased by 9.48% to -$5.3 million in 2023, then plummeted by 45.34% to -$7.7 million in 2024, then fell by 6.62% to -$8.2 million in 2025.
  • Business Quant data shows Free Cash Flow for BNTC at -$8.2 million in Q2 2025, -$3.1 million in Q1 2025, and -$7.7 million in Q4 2024.